Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023
Pragna Patel(Northwestern University), Sara J. Vagi(Computer Emergency Response Team), Hannah G. Rosenblum(National Center for Immunization and Respiratory Diseases), Brendan R. Jackson(Centers for Disease Control and Prevention), Evelyn Twentyman(Synaptic Research (United States)), Shannon Griffin-Blake(Computer Emergency Response Team), Emily H. Koumans(Computer Emergency Response Team)
Cited by 18
Related Papers
Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
|Clinical Infectious Diseases|2016|1.6k
Outbreak-associated<i>Salmonella enterica</i>Serotypes and Food Commodities, United States, 1998–2008
|Emerging infectious diseases|2013|485
Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions — United States, January–May 2020
|MMWR Morbidity and Mortality Weekly Report|2020|378
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
|Preventing Chronic Disease|2021|370
Cumulative Incidence of Cancer Among Persons With HIV in North America
|Annals of Internal Medicine|2015|330